Contribution of Age-Related Microvascular Dysfunction to Abnormal Coronary: Hemodynamics in Patients With Ischemic

Tim P van de Hoef1, Mauro Echavarria-Pinto2, Martijn Meuwissen3

  • 1Amsterdam UMC, University of Amsterdam, Heart Center, Department of Interventional Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands; Cardiovascular Institute, Hospital Clínico San Carlos, and Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Insights

Aging worsens coronary microvascular function, increasing the risk of ischemic heart disease. This age-related decline in coronary flow reserve is not fully captured by pressure measurements alone.

Area of Science:

  • Cardiovascular physiology
  • Geriatric cardiology
  • Vascular biology

Background:

  • Coronary atherosclerosis impairs myocardial blood supply.
  • Age-related microcirculatory changes can exacerbate this impairment.

Purpose of the Study:

  • To investigate how age-related microcirculatory dysfunction contributes to abnormal coronary hemodynamics in patients with coronary atherosclerosis.
  • To analyze the association of aging with coronary hemodynamics in both unobstructed and stenosed arteries.

Main Methods:

  • Intracoronary pressure and flow were measured using Doppler and thermodilution techniques in 228 patients (299 vessels) and 99 patients (120 vessels), respectively.
  • Doppler measurements were also performed in unobstructed vessels in 172 patients.
  • Coronary hemodynamics were assessed in relation to age in both stenosed and unobstructed coronary arteries.

Main Results:

  • Advancing age correlated with increased minimal microvascular resistance and decreased hyperemic flow in all coronary arteries, leading to reduced coronary flow reserve.
  • Fractional flow reserve increased with age, while epicardial stenosis severity remained consistent across age groups.
  • The risk of combined epicardial and microvascular disease patterns increased with age, whereas the risk of non-flow-limiting stenosis with healthy microcirculation decreased.

Conclusions:

  • Aging progressively impairs coronary vasodilatory capacity due to increased minimal microvascular resistance.
  • Age-related microvascular dysfunction is a key factor in ischemic heart disease pathophysiology.
  • Hyperemic coronary pressure measurements alone may not adequately identify aging-related microvascular impairment.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
813
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
313
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
154